| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,238 |
1,706 |
$680K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,841 |
2,272 |
$549K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,739 |
6,832 |
$299K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,716 |
1,167 |
$268K |
| 80053 |
Comprehensive metabolic panel |
5,153 |
3,861 |
$263K |
| G0378 |
Hospital observation service, per hour |
942 |
580 |
$216K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
573 |
441 |
$195K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,314 |
3,154 |
$103K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
485 |
476 |
$89K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
589 |
476 |
$83K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,644 |
1,922 |
$76K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
709 |
533 |
$73K |
| 36415 |
Collection of venous blood by venipuncture |
6,781 |
5,045 |
$70K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,445 |
1,174 |
$69K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
651 |
461 |
$67K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,110 |
2,836 |
$57K |
| 87400 |
|
700 |
689 |
$54K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
810 |
647 |
$49K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
810 |
647 |
$48K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
139 |
131 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
806 |
691 |
$43K |
| 97161 |
|
593 |
454 |
$37K |
| J3490 |
Unclassified drugs |
3,043 |
1,481 |
$35K |
| 59025 |
Fetal non-stress test |
213 |
120 |
$35K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,186 |
1,040 |
$31K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
733 |
540 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,254 |
1,062 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
909 |
717 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
479 |
469 |
$28K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
230 |
43 |
$26K |
| 71046 |
Radiologic examination, chest; 2 views |
163 |
145 |
$24K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
364 |
267 |
$24K |
| 81001 |
|
1,567 |
1,290 |
$23K |
| 87631 |
|
141 |
123 |
$22K |
| 71045 |
Radiologic examination, chest; single view |
243 |
187 |
$22K |
| 87081 |
|
599 |
587 |
$22K |
| 81025 |
|
822 |
616 |
$21K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
130 |
90 |
$21K |
| 86141 |
|
688 |
546 |
$21K |
| 87088 |
|
477 |
440 |
$19K |
| 85027 |
|
657 |
456 |
$18K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
395 |
347 |
$18K |
| 80305 |
|
461 |
357 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
647 |
483 |
$17K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
426 |
302 |
$16K |
| 87210 |
|
662 |
545 |
$15K |
| 80061 |
Lipid panel |
742 |
628 |
$15K |
| 84484 |
|
304 |
183 |
$14K |
| 87420 |
|
216 |
208 |
$14K |
| 81003 |
|
805 |
651 |
$11K |
| 81002 |
|
732 |
589 |
$11K |
| 84702 |
|
280 |
162 |
$9K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
69 |
54 |
$9K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
193 |
54 |
$8K |
| 85610 |
|
670 |
517 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
40 |
26 |
$7K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
242 |
171 |
$7K |
| 83690 |
|
330 |
274 |
$7K |
| 76801 |
|
28 |
25 |
$7K |
| J2704 |
Injection, propofol, 10 mg |
170 |
134 |
$6K |
| 73630 |
|
34 |
26 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
31 |
25 |
$6K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
183 |
94 |
$6K |
| 85730 |
|
198 |
185 |
$5K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
92 |
37 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
159 |
138 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
246 |
194 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
143 |
89 |
$4K |
| 80055 |
|
28 |
25 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
135 |
116 |
$3K |
| 85007 |
|
121 |
79 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
319 |
196 |
$3K |
| 88142 |
|
87 |
84 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
15 |
15 |
$2K |
| 82950 |
|
96 |
91 |
$2K |
| 87077 |
|
86 |
66 |
$2K |
| 85379 |
|
71 |
40 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
27 |
$2K |
| 87186 |
|
65 |
53 |
$2K |
| 84703 |
|
65 |
63 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
74 |
69 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
12 |
$2K |
| 86780 |
|
54 |
52 |
$2K |
| 86901 |
|
97 |
90 |
$1K |
| 82570 |
|
42 |
37 |
$1K |
| 99201 |
|
93 |
91 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
63 |
63 |
$1K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
18 |
$942.80 |
| 83880 |
|
14 |
13 |
$936.04 |
| 84145 |
|
21 |
12 |
$875.15 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
32 |
30 |
$832.06 |
| 86900 |
|
33 |
31 |
$749.38 |
| 83605 |
|
70 |
48 |
$737.07 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
14 |
14 |
$733.02 |
| 86850 |
|
18 |
17 |
$705.83 |
| 84439 |
|
26 |
24 |
$671.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
14 |
14 |
$543.51 |
| 87340 |
|
12 |
12 |
$504.17 |
| 82150 |
|
13 |
12 |
$481.64 |
| 86140 |
|
12 |
12 |
$352.80 |
| 86762 |
|
12 |
12 |
$345.07 |
| A9270 |
Non-covered item or service |
226 |
65 |
$340.93 |
| 83735 |
|
14 |
13 |
$284.80 |
| 85018 |
|
15 |
13 |
$186.11 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$172.80 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
14 |
12 |
$0.00 |